Abstract
The goal of platelet function testing in the catheterization laboratory is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events and optimization of anti-platelet therapy for percutaneous interventions. We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFA™, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk.
| Original language | English |
|---|---|
| Pages (from-to) | 151-154 |
| Number of pages | 4 |
| Journal | Journal of Thrombosis and Thrombolysis |
| Volume | 11 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2001 |
Keywords
- Abciximab
- Coronary artery disease
- GP IIb/IIIa inhibitor
- Percutaneous intervention
- Platelet
ASJC Scopus subject areas
- Hematology
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver